A Multicenter Single-arm Extension Study to Characterize the Long-term Safety of Cinacalcet Hydrochloride in the Treatment of Secondary Hyperparathyroidism in Pediatric Subjects With Chronic Kidney Disease on Dialysis
Phase of Trial: Phase III
Latest Information Update: 23 Feb 2018
At a glance
- Drugs Cinacalcet (Primary)
- Indications Secondary hyperparathyroidism
- Focus Adverse reactions
- Sponsors Amgen
- 10 Jun 2017 Biomarkers information updated
- 21 Mar 2017 Status changed from active, no longer recruiting to completed.
- 23 Dec 2016 This trial has been completed in Czech Republic.